ASCO, ACCC to increase participation of underrepresented populations in cancer trials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The American Society of Clinical Oncology and Association of Community Cancer Centers are working to foster participation in cancer treatment trials to more fully reflect the diversity of people at risk for or living with cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

As the chief scientific officer of the Leukemia & Lymphoma Society for the past eleven years, it has been a privilege to lead a group of scientists that has doled out more than $600 million for cutting-edge hematologic oncology research. These dollars went to more than 1,000 research projects through initiatives like our biomedical research grant programs and LLS’s venture philanthropy, the Therapy Acceleration Program (TAP). 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login